NR3C1 and cancer: Mechanistically, data show that glucocorticoids induce resistance to apoptosis, suppress the fraction of cancer cells found in the chemotherapy-sensitive S-phase, and decrease the gene transcription of drug transporters, especially in cancer cells with high GR expression [29,30].